EconPapers    
Economics at your fingertips  
 

Details about Christopher James Sampson

E-mail:
Homepage:http://www.chrissampson.me
Phone:+44 (0)20 7747 8866
Postal address:Southside, 7th Floor, 105 Victoria Street, London SW1E 6QT UK
Workplace:Office of Health Economics, (more information at EDIRC)

Access statistics for papers by Christopher James Sampson.

Last updated 2024-09-09. Update your information in the RePEc Author Service.

Short-id: psa1048


Jump to Journal Articles

Working Papers

2023

  1. The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
    Contract Research, Office of Health Economics Downloads

2021

  1. How is Quality of Life Measured for Health Technology Assessments?
    Briefing, Office of Health Economics Downloads

2020

  1. Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?
    Grant-Funded Research, Office of Health Economics Downloads

2019

  1. How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy
    Briefing, Office of Health Economics Downloads View citations (3)

2018

  1. Barriers to Uptake of Minimal Access Surgery in the United Kingdom
    Contract Research, Office of Health Economics Downloads
  2. R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
    Grant-Funded Research, Office of Health Economics Downloads View citations (1)
  3. The Impact of New Medicines in the NHS: 70 Years of Innovation
    Contract Research, Office of Health Economics Downloads

2013

  1. Cost implications of treatment non-completion in a forensic personality disorder service
    MPRA Paper, University Library of Munich, Germany Downloads
  2. Happy and healthy: a joint model of health and life satisfaction
    MPRA Paper, University Library of Munich, Germany Downloads
  3. The relationship between individual risk and cost-effectiveness in screening interventions
    MPRA Paper, University Library of Munich, Germany Downloads

Journal Articles

2024

  1. Is anchoring at ‘dead’ a theoretical requirement for health state valuation?
    Health Economics, 2024, 33, (9), 1929-1935 Downloads
  2. Marginal cost per QALY estimates: What are they good for?
    Health Policy, 2024, 142, (C) Downloads

2022

  1. NICE and the EQ-5D-5L: Ten Years Trouble
    PharmacoEconomics - Open, 2022, 6, (1), 5-8 Downloads
  2. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
    Applied Health Economics and Health Policy, 2022, 20, (5), 651-667 Downloads View citations (1)

2021

  1. Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al
    Medical Decision Making, 2021, 41, (3), 255-257 Downloads View citations (1)

2019

  1. Transparency in Decision Modelling: What, Why, Who and How?
    PharmacoEconomics, 2019, 37, (11), 1355-1369 Downloads View citations (3)

2017

  1. Model Registration: A Call to Action
    PharmacoEconomics - Open, 2017, 1, (2), 73-77 Downloads View citations (4)

2013

  1. Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776
    The European Journal of Health Economics, 2013, 14, (4), 703-705 Downloads
 
Page updated 2025-02-04